BTIG Reiterates Neutral Rating on Bionano Genomics (BNGO)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Ladenburg Thalmann Downgrades Bionano Genomics (BNGO) to Neutral
November 15, 2024 6:42 AM ESTLadenburg Thalmann analyst Jeffrey Cohen downgraded Bionano Genomics (NASDAQ: BNGO) from Buy to Neutral.
For an analyst ratings summary and ratings history on Bionano Genomics click here. For more ratings news on Bionano Genomics click here.
Shares of Bionano Genomics closed at $0.26 yesterday.
... More


